Trident Texofab
New to Zerodha? Sign-up for free.
New to Zerodha? Sign-up for free.
Get instant stock alerts
- Share Price
- Financials
- Revenue mix
- Shareholdings
- Peers
- Forensics
Share Price
Coming soon
- 5D
- 1M
- 6M
- YTD
- 1Y
- 5Y
- MAX
Financials
-
Summary
-
Profit & Loss
-
Balance sheet
-
Cashflow
This data is currently unavailable for this company.
| (In Cr.) |
|---|
| (In Cr.) | ||||
|---|---|---|---|---|
|
This data is currently unavailable for this company. |
| (In %) |
|---|
| (In Cr.) |
|---|
| Financial Year (In Cr.) |
|---|
Revenue mix
-
Product wise
-
Location wise
Revenue Mix
This data is currently unavailable for this company.
Revenue Mix
This data is currently unavailable for this company.
Forensics
Recent events
-
News
-
Corporate Actions
Trident Texofab Ltd. said it has forfeited 9,11,479 fully convertible warrants that were not exercised by the June 22, 2026 deadline. The warrants were originally allotted in December 2024 as part of a preferential issue, with holders paying 25 percent of the Rs 70 issue price upfront. The forfeited upfront amount totals Rs 1.59 crore, which the company will now retain. All outstanding warrants have lapsed, and no fresh equity shares were issued, leaving the paid-up capital unchanged.
Powered by Tijori
Trident Texofab Ltd. said it has forfeited 9,11,479 fully convertible warrants that were not exercised by the June 22, 2026 deadline. The warrants were originally allotted in December 2024 as part of a preferential issue, with holders paying 25 percent of the Rs 70 issue price upfront. The forfeited upfront amount totals Rs 1.59 crore, which the company will now retain. All outstanding warrants have lapsed, and no fresh equity shares were issued, leaving the paid-up capital unchanged.
Powered by Tijori
Feb 14 (Reuters) - Trident Texofab Ltd TRDT.BO:
CFO RAHUL JARIWALA RESIGNS
NAMES JENISH JARIWALA AS CFO
Source text for Eikon: ID:nBSEtZdHl
Further company coverage: TRDT.BO
(([email protected];;))
Feb 14 (Reuters) - Trident Texofab Ltd TRDT.BO:
CFO RAHUL JARIWALA RESIGNS
NAMES JENISH JARIWALA AS CFO
Source text for Eikon: ID:nBSEtZdHl
Further company coverage: TRDT.BO
(([email protected];;))
More Nano Cap Ideas
See similar 'Nano' cap companies with recent activity
Promoter Buying
Companies where the promoters are bullish
Capex
Companies investing on expansion
Superstar Investor
Companies where well known investors have invested
Popular questions
- Business
- Financials
- Share Price
- Shareholdings
What does Trident Texofab do?
Trident Texofab Limited is a leading semi-composite textile company offering a diverse range of products such as home furnishing, garments, suiting, shirting, and technical textiles. In FY19, the company expanded operations to manufacture polyester and poly-blend fabrics.
Who are the competitors of Trident Texofab?
Trident Texofab major competitors are Spright Agro, SVP Global Textiles, Celebrity Fashions, Dhanlaxmi Fabrics, Shree Shaleen Text., Vinny Overseas, Shubham Polyspin. Market Cap of Trident Texofab is ₹48 Crs. While the median market cap of its peers are ₹49 Crs.
Is Trident Texofab financially stable compared to its competitors?
Trident Texofab seems to be less financially stable compared to its competitors. Altman Z score of Trident Texofab is 2.59 and is ranked 5 out of its 8 competitors.
Does Trident Texofab pay decent dividends?
The company seems to be paying a very low dividend. Investors need to see where the company is allocating its profits. Trident Texofab latest dividend payout ratio is 0% and 3yr average dividend payout ratio is 0%
How has Trident Texofab allocated its funds?
Companies resources are allocated to majorly unproductive assets like Short Term Loans & Advances
How strong is Trident Texofab balance sheet?
Balance sheet of Trident Texofab is moderately strong.
Is the profitablity of Trident Texofab improving?
The profit is oscillating. The profit of Trident Texofab is ₹0.7 Crs for TTM, ₹2.45 Crs for Mar 2025 and ₹1.08 Crs for Mar 2024.
Is the debt of Trident Texofab increasing or decreasing?
Yes, The net debt of Trident Texofab is increasing. Latest net debt of Trident Texofab is ₹33.49 Crs as of Mar-26. This is greater than Mar-25 when it was ₹20.29 Crs.
Is Trident Texofab stock expensive?
Trident Texofab is not expensive. Latest PE of Trident Texofab is 68.01, while 3 year average PE is 70.7. Also latest EV/EBITDA of Trident Texofab is 15.96 while 3yr average is 31.39.
Has the share price of Trident Texofab grown faster than its competition?
Trident Texofab has given lower returns compared to its competitors. Trident Texofab has grown at ~-2.69% over the last 7yrs while peers have grown at a median rate of 0.16%
Is the promoter bullish about Trident Texofab?
Promoters stake in the company seems stable, and we need to go through filings and allocation of resources to gauge promoter bullishness. Latest quarter promoter holding in Trident Texofab is 32.16% and last quarter promoter holding is 32.16%.
Are mutual funds buying/selling Trident Texofab?
There is Insufficient data to gauge this.